Page 4 - Les meilleurs doctors traitant la maladie suivante : Cancer rectal - TOP -113 des médecins

Plus de 30 ans de spécialisation en virothérapie – Le Dr Jaunalksne dirige le centre d'immunologie clinique de l'hôpital universitaire clinique Pauls Stradins.

• Diriger le centre d'immunologie clinique d'un grand hôpital universitaire
• Être diplômé de l'Institut de médecine de Riga avec un internat en médecine interne
• Se concentrer sur des approches immunologiques de pointe

Le Dr Alemdar est spécialisé en oncologie médicale, avec un accent particulier sur les plans de traitement personnalisés pour les patients atteints de cancer du rectum.

• Diplômé de la faculté de médecine de l'université de Kocaeli
• Spécialisation en oncologie médicale à l'université d'Akdeniz
• Vaste expérience dans divers hôpitaux à travers la Turquie
• Pratique actuellement au complexe hospitalier Medical Park d'Antalya

Le Dr Auala Hubert dirige le centre des cancers gastro-intestinaux au centre médical Hadassah, avec 33 ans d'expérience axés sur l'oncologie et la radiothérapie.

• Se spécialiser en oncologie médicale et radiothérapie
• Chef du centre des cancers gastro-intestinaux
• Certifié en oncologie et radiothérapie
• Membre de la Société israélienne d'oncologie clinique
• Formé à l'Université hébraïque et à l'hôpital universitaire Hadassah

Le Dr Ercan Ozden a été formé à la prestigieuse université d'Istanbul et se spécialise en oncologie médicale, avec un accent particulier sur le cancer du rectum.

• Terminer sa surspécialisation en oncologie médicale à l'université de Kocaeli
• Avoir plus d'une décennie d'expérience en médecine interne
• Pratiquer dans plusieurs hôpitaux de renom en Turquie
• Être diplômé du programme de médecine en anglais de l'université d'Istanbul

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Le Dr Joseba Rebollo Liceaga possède plus de 30 ans d'expérience en oncologie, se spécialisant dans le cancer du rectum au Quironsalud Torrevieja.

• Chef du service d'oncologie à la Clínica San Miguel de Navarra pendant 13 ans
• Rédiger des recherches sur l'électrochimiothérapie et les traitements multidisciplinaires
• Spécialiste en oncologie médicale de la Clínica Universidad de Navarra
• Médecin associé à la Faculté de Médecine de l'Université de Navarre

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Le Dr Kinas est spécialisé en chirurgie oncologique et colorectale, avec une vaste expérience dans le traitement du cancer du rectum aux hôpitaux Büyük Anadolu.

• Être qualifié dans les techniques chirurgicales traditionnelles et avancées
• Se concentrer sur les chirurgies du cancer du pancréas, des voies biliaires et du côlon
• Être également expérimenté en chirurgie bariatrique métabolique et du diabète

Plus de 15 000 interventions chirurgicales en 25 ans – Le Dr de Lacy est spécialisé dans les techniques mini-invasives pour le cancer du rectum à l'Hôpital Quiron Barcelone.

• Réaliser plus de 1 000 chirurgies mini-invasives par an
• Être le pionnier de la technique TaTME pour le cancer du rectum
• Être le président de l'Association des chirurgiens-endoscopistes en Europe
• Être le conférencier sur les techniques avancées de laparoscopie

Le Dr Zalmanova est spécialisée en radiothérapie pour le cancer du rectum au centre médical Assuta.

• Radiothérapeute spécialisée dans le traitement du cancer du rectum
• Travailler au centre médical Assuta, un établissement d'oncologie de premier plan
• Se consacrer à des plans de traitement personnalisés pour chaque patient

Diplômé d'honneur de l'Université Hacettepe, spécialisé dans la nutrition des patients cancéreux et les soins post-chirurgie bariatrique.

• Mener des recherches sur la relation entre la nutrition et les maladies chroniques
• Effectuer des stages dans les meilleurs hôpitaux, dont l'hôpital d'oncologie de l'Université Hacettepe
• Suivre des cours spécialisés en nutrition bariatrique et obésité
• Travailler avec divers groupes de patients, notamment les patients atteints de cancer et de diabète

Il dirige le département de chirurgie du centre médical Hadassah, se consacrant exclusivement au cancer colorectal et aux tumeurs malignes de la peau.

• Se spécialiser dans le traitement du cancer colorectal
• Diriger le département de chirurgie du centre médical Hadassah
• Axer sa pratique clinique sur les cancers colorectaux et de la peau

Le Dr Beny dirige le service des tumeurs malignes gastro-intestinales au centre médical Rambam, se concentrant spécifiquement sur les cancers de l'appareil digestif.

• Médecin senior avec plus de 20 ans d'expérience en oncologie médicale et radiothérapie
• Diriger une clinique dédiée à l'oncologie gastro-intestinale pour des soins ciblés
• Certifié par le conseil de l'ordre en Israël avec des qualifications médicales de la Communauté européenne
• Suivre des cours de formation avancée, y compris un cours de l'ESTRO sur la curiethérapie moderne